426 related articles for article (PubMed ID: 6230668)
41. Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3.
Vĕtvicka V; Reed W; Hoover ML; Ross GD
J Immunol; 1993 May; 150(9):4052-60. PubMed ID: 8473749
[TBL] [Abstract][Full Text] [Related]
42. Biochemical and antigenic analysis of the Epstein Barr virus/C3d receptor (CR2).
Siaw MF; Nemerow GR; Cooper NR
J Immunol; 1986 Jun; 136(11):4146-51. PubMed ID: 3009616
[TBL] [Abstract][Full Text] [Related]
43. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
Fearon DT
J Exp Med; 1980 Jul; 152(1):20-30. PubMed ID: 6967510
[TBL] [Abstract][Full Text] [Related]
44. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin.
Lambris JD; Dobson NJ; Ross GD
J Exp Med; 1980 Dec; 152(6):1625-44. PubMed ID: 6450259
[TBL] [Abstract][Full Text] [Related]
45. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
46. Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines.
Cohen JH; Fischer E; Kazatchkine MD; Lenoir GM; Lefevre-Delvincourt C; Revillard JP
Scand J Immunol; 1987 Jun; 25(6):587-98. PubMed ID: 3037684
[TBL] [Abstract][Full Text] [Related]
47. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
Wilson JG; Ratnoff WD; Schur PH; Fearon DT
Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
[TBL] [Abstract][Full Text] [Related]
48. Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells.
Thornton BP; Vetvicka V; Ross GD
Clin Exp Immunol; 1996 Jun; 104(3):531-7. PubMed ID: 9099940
[TBL] [Abstract][Full Text] [Related]
49. Ligands of CR2 do not interfere with C3 fragment fixation or enhanced NK sensitivity of Raji cells treated with human serum.
Yefenof E; Ramos OF; Nilsson B; Klein E
Immunol Lett; 1989 Jun; 21(4):303-6. PubMed ID: 2527817
[TBL] [Abstract][Full Text] [Related]
50. Characterization of three monoclonal antibodies against C3 with selective specificities.
Iida K; Mitomo K; Fujita T; Tamura N
Immunology; 1987 Nov; 62(3):413-7. PubMed ID: 2444528
[TBL] [Abstract][Full Text] [Related]
51. CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells.
Mold C; Nemerow GR; Bradt BM; Cooper NR
J Immunol; 1988 Mar; 140(6):1923-9. PubMed ID: 2831273
[TBL] [Abstract][Full Text] [Related]
52. Identification of murine complement receptor type 2.
Fingeroth JD; Benedict MA; Levy DN; Strominger JL
Proc Natl Acad Sci U S A; 1989 Jan; 86(1):242-6. PubMed ID: 2783485
[TBL] [Abstract][Full Text] [Related]
53. Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment.
Cooper NR; Moore MD; Nemerow GR
Annu Rev Immunol; 1988; 6():85-113. PubMed ID: 2838050
[No Abstract] [Full Text] [Related]
54. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
Lambris JD; Ross GD
J Immunol; 1982 Jan; 128(1):186-9. PubMed ID: 7033372
[TBL] [Abstract][Full Text] [Related]
55. Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.
Huemer HP; Wang Y; Garred P; Koistinen V; Oppermann S
Immunology; 1993 Aug; 79(4):639-47. PubMed ID: 8406590
[TBL] [Abstract][Full Text] [Related]
56. Cell cycle control of activated, synchronized murine B lymphocytes--roles of macrophages and complement C3.
Melchers F; Erdei A; Corbel C; Leptin M; Schulz T; Dierich MP
Mol Immunol; 1986 Nov; 23(11):1173-6. PubMed ID: 2950314
[TBL] [Abstract][Full Text] [Related]
57. Activation of human platelets through gp140, the C3d/EBV receptor (CR2).
Nunez D; Charriaut-Marlangue C; Barel M; Benveniste J; Frade R
Eur J Immunol; 1987 Apr; 17(4):515-20. PubMed ID: 2952514
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
Fischer E; Appay MD; Cook J; Kazatchkine MD
J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
[TBL] [Abstract][Full Text] [Related]
59. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.
Molina H; Kinoshita T; Webster CB; Holers VM
J Immunol; 1994 Jul; 153(2):789-95. PubMed ID: 8021513
[TBL] [Abstract][Full Text] [Related]
60. Purification of the Epstein-Barr virus/C3d complement receptor of human B lymphocytes: antigenic and functional properties of the purified protein.
Nemerow GR; Siaw MF; Cooper NR
J Virol; 1986 May; 58(2):709-12. PubMed ID: 2422399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
